Loading
Radiomics and Machine Learning in Medical Imaging / Artificial Intelligence in Healthcare and Education / Ai in Cancer Detection · Journal article
Future Journal of Pharmaceuticals and Health Sciences · September 5, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review article that discusses conceptual and potential applications of artificial intelligence in cancer diagnosis, treatment personalisation, and drug discovery, along with ethical and regulatory considerations. It does not report original empirical data, quantified outcomes, or comparative evidence to support any specific clinical claim.
Journal article.
AI systems show promise in interpreting medical imaging and often outperform human specialists, though no specific performance metrics or studies are cited. AI-driven predictive models combining genetic, lifestyle, and environmental data are described as showing promise for cancer risk determination, without reported evidence. AI is stated to accelerate drug discovery and repurposing for cancer therapies, with emphasis on ethical concerns including algorithmic bias and privacy risks.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a narrative review that raises questions about AI applications in cancer diagnosis and treatment without reporting original data, controlled comparisons, or quantified evidence of clinical outcomes.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Cancer is a major worldwide health concern, necessitating the development of novel strategies to improve detection and treatment outcomes. The present study delves into the significant contributions that artificial intelligence (AI) has made to the field o f cancer. It specifically highlights the applications of AI in diagnosis, personalized treatment, and clinical trial optimization. Diagnostic procedures have been transformed by recent advances in AI, particularly through the use of machine learning and de ep learning techniques. AI systems are becoming more and more accurate at interpreting medical imaging, including radiographs and histopathology slides, often outperforming human specialists in this regard. Furthermore, by combining genetic, lifestyle, and environmental data, AI - driven predictive models are showing promise in determining a person's risk of developing cancer. Artificial intelligence is a key factor in the advancement of personalized medicine in the field of cancer treatment. AI can assist me dical professionals in determining the best course of action for each patient by combining vast datasets from clinical trials and genomic research. Furthermore, AI is expediting the process of finding new drugs and repurposing old ones for cancer therapies. Additionally, this review discusses ethical concerns about the use of AI, such as algorithmic bias and privacy concerns pertaining to patient data. The application of AI technologies in oncology emphasises how important it is to have strong regulatory fr ameworks in place to guarantee patient safety and fair access to treatment.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.